CDC-RFA-PS23-0013: Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCHHSTP notices from 2023.
Centers for Disease Control - NCHHSTP offered grants to any type of organization. It expected to make one award worth $3.8 million in total. Applications closed on June 6, 2023.
From the official notice on Grants.gov, last changed April 5, 2023. Checked November 7, 2026.
- Total funding$3.8 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | April 5, 2023 |
|---|---|
| Deadline | June 6, 2023 |
| Archived by Grants.gov | July 4, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 13 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Most of the program's money (60% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The NOFO supports program activities to achieve and maintain the elimination of perinatal HIV transmission in the United States and to optimize the health and wellbeing of people with HIV, their infants, and all persons with perinatally acquired HIV. The recipient will collaborate with CDC over a 5 year period of performance to establish a National Resource Center for the implementation of CDC’s Framework for the Elimination of Perinatal HIV in the United States and will convene a Task Force of subject matter experts from public health, clinical care and persons living with HIV to develop innovative approaches to optimize perinatal, maternal/parental and infant health for persons affected by HIV. The recipient will also disseminate resources and technical assistance through large educational and best-practice-sharing networks. These activities will result in an increased awareness by clinical and public health professionals of strategies to achieve and maintain elimination of perinatal HIV in the United States as well as approaches to optimize the health of families affected by HIV. The provision of technical assistance and capacity building to improve perinatal HIV care and prevention systems will also create opportunities to utilize aspects of The Framework for the prevention of congenital syphilis or other perinatal infections. In 2012, CDC published a framework for the elimination of perinatal HIV transmission in the United States (The Framework). Based on the latest national data, elimination of perinatal HIV transmission may have occurred in the United States: in 2019, CDC received 32 reports of U.S.-born infants with diagnosed perinatal infection. To maintain low numbers of diagnoses of perinatal HIV each year, and to ensure the short- and long-term safety of perinatal HIV prevention interventions, it will be necessary to build upon past work to implement The Framework.
Who has won HIV Prevention Activities Non-Governmental Organization Based grants before
From fiscal 2021 to 2025, HIV Prevention Activities Non-Governmental Organization Based (93.939) awarded $965 million across 242 grant awards, an average of $4.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Florida Department of Health | Florida | 1 | $60.1 million |
| City of New York | New York | 1 | $53.6 million |
| Emory University | Georgia | 1 | $47.3 million |
| California Department of Public Health | California | 1 | $37.9 million |
| Department of State Health Services | Texas | 1 | $37.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PS23-0013 still open?
No. It closed on June 6, 2023.
Who can apply for Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States?
Centers for Disease Control - NCHHSTP accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States?
Closed June 6, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $3.8 million in total for one award.
Who has won HIV Prevention Activities Non-Governmental Organization Based grants before?
The largest recipients over five fiscal years were Florida Department of Health, City of New York, Emory University. The program made 242 awards worth $965 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)